Plus, with yesterday's news of Cigna capping out of pocket costs for Wegovy and Zepbound to just $200, some truly positive strides are being made towards accessibility
Postprandial renal haemodynamic effect of lixisenatide versus once-daily insulin glulisine in type 2 diabetes patients on insulin-glargine: an 8-week, randomised, open-label trial
The worldwide AAV gene therapy market is experiencing significant expansion, with projections indicating a revenue increase reaching several hundred million dollars by the end of the forecast period, spanning 2025 to 2034
Improve how your body handles insulin / blood sugar (very helpful in type 2 diabetes)
Even if you continue lifestyle interventions and youre eating healthy and exercising, you can still regain at least 3% or 4% of your body weight. Over the course of your treatment, your healthcare provider will gradually increase how much semaglutide youll take until youve reached your desired weight or hit the maximum allowable dose
Ongoing research is exploring their potential role across a range of conditions, including cardiovascular disease prevention, metabolic liver disease, and addictions medicine
.png.jpg)
